{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:35Z","timestamp":1791223655496,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1038\/npp.2012.40","type":"journal-article","created":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T07:07:53Z","timestamp":1334128073000},"page":"1934-1944","source":"Crossref","is-referenced-by-count":70,"title":["Reduced Tissue Levels of Noradrenaline Are Associated with Behavioral Phenotypes of the TgCRND8 Mouse Model of Alzheimer's Disease"],"prefix":"10.1038","volume":"37","author":[{"given":"Beverly M","family":"Francis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enid","family":"Hajderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadeta","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnne","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Fahnestock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard T J","family":"Mount","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"BFnpp201240_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1192\/bjp.135.3.216","volume":"135","author":"R Adolfsson","year":"1979","unstructured":"Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979). Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135: 216\u2013223.","journal-title":"Br J Psychiatry"},{"key":"BFnpp201240_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.neurobiolaging.2007.11.010","volume":"30","author":"O Ambree","year":"2009","unstructured":"Ambree O, Richter H, Sachser N, Lewejohann L, Dere E, de Souza Silva MA et al (2009). Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease. Neurobiol Aging 30: 1191\u20131204.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1530-0277.2010.01182.x","volume":"34","author":"ET Barfield","year":"2010","unstructured":"Barfield ET, Barry SM, Hodgin HB, Thompson BM, Allen SS, Grisel JE (2010). \u03b2-endorphin mediates behavioral despair and the effect of ethanol on the tail suspension test in mice. Alcohol Clin Exp Res 34: 1066\u20131072.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201240_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.nbd.2006.03.012","volume":"23","author":"A Bellucci","year":"2006","unstructured":"Bellucci A, Luccarini I, Scali C, Prosperi C, Garzia M, Giovannini MG et al (2006). Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice. Neurobiol Dis 23: 260\u2013272.","journal-title":"Neurobiol Dis"},{"key":"BFnpp201240_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","volume":"42","author":"CW Berridge","year":"2003","unstructured":"Berridge CW, Waterhouse BD (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42: 33\u201384.","journal-title":"Brain Res Rev"},{"key":"BFnpp201240_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1212\/WNL.32.2.164","volume":"32","author":"W Bondareff","year":"1982","unstructured":"Bondareff W, Mountjoy CQ, Roth M (1982). Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Neurology 32: 164\u2013168.","journal-title":"Neurology"},{"key":"BFnpp201240_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","volume":"1","author":"W Bondareff","year":"1987","unstructured":"Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP et al (1987). Neuronal degeneration in locus coeruleus and cortical correlates of Alzheimer's disease. Alzheimer Dis Assoc Discord 1: 256\u2013262.","journal-title":"Alzheimer Dis Assoc Discord"},{"key":"BFnpp201240_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239\u2013259.","journal-title":"Acta Neuropathol (Berl)"},{"key":"BFnpp201240_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","volume":"25","author":"H Braak","year":"2004","unstructured":"Braak H, Del Tredici K (2004). Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-\u03b2 formation. Neurobiol Aging 25: 713\u2013718.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR10","doi-asserted-by":"publisher","first-page":"21418","DOI":"10.1074\/jbc.M413955200","volume":"280","author":"L Chen","year":"2005","unstructured":"Chen L, Cagniard B, Mathews T, Jones S, Koh HC, Ding Y et al (2005). Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice. J Biol Chem 280: 21418\u201321426.","journal-title":"J Biol Chem"},{"key":"BFnpp201240_CR11","doi-asserted-by":"publisher","first-page":"21562","DOI":"10.1074\/jbc.M100710200","volume":"276","author":"MA Chishti","year":"2001","unstructured":"Chishti MA, Yang D, Janus C, Phinney A, Horne P, Pearson J et al (2001). Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276: 21562\u201321570.","journal-title":"J Biol Chem"},{"key":"BFnpp201240_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1124\/jpet.301.1.187","volume":"301","author":"P Chopin","year":"2002","unstructured":"Chopin P, Colpaert FC, Marien M (2002). Effects of acute and subchronic administration of dexefaroxan, an \u03b12-adrenoceptor antagonist, on memory performance in young adult and aged rodents. J Pharmacol Exp Ther 301: 187\u2013196.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201240_CR13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1471-4159.2010.06622.x","volume":"113","author":"S Counts","year":"2010","unstructured":"Counts S, Mufson E (2010). Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity. J Neurochem 113: 649\u2013660.","journal-title":"J Neurochem"},{"key":"BFnpp201240_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0896-6273(03)00195-8","volume":"38","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38: 57\u2013160.","journal-title":"Neuron"},{"key":"BFnpp201240_CR15","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983). Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184\u20131190.","journal-title":"Science"},{"key":"BFnpp201240_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571\u2013625.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201240_CR17","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976). Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403.","journal-title":"Lancet"},{"key":"BFnpp201240_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0306-4522(02)00406-2","volume":"115","author":"T Debeir","year":"2002","unstructured":"Debeir T, Marien M, Chopin P, Martel J-C, Colpaert F, Raisman-Vozari R (2002). Protective effects of the \u03b12-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat. Neuroscience 115: 41\u201353.","journal-title":"Neuroscience"},{"key":"BFnpp201240_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0197-4580(97)00114-0","volume":"18","author":"L DeToledo-Morrell","year":"1997","unstructured":"DeToledo-Morrell L, Sullivan MP, Morrell F, Wilson RS, Bennett DA, Spencer S (1997). Alzheimer's disease: in vivo detection of differential vulnerability of brain regions. Neurobiol Aging 18: 463\u2013468.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0166-4328(00)00261-8","volume":"115","author":"HC Dringenberg","year":"2000","unstructured":"Dringenberg HC (2000). Alzheimer's disease: more than a \u2018cholinergic disorder\u2019-evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115: 235\u2013249.","journal-title":"Behav Brain Res"},{"key":"BFnpp201240_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF01245220","volume":"49","author":"G Engberg","year":"1980","unstructured":"Engberg G, Svensson TH (1980). Pharmacological analysis of a cholinergic receptor mediated regulation of brain norepinephrine neurons. J Neural Transm 49: 137\u2013150.","journal-title":"J Neural Transm"},{"key":"BFnpp201240_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0149-2918(04)90172-5","volume":"26","author":"SI Finkel","year":"2004","unstructured":"Finkel SI (2004). Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease. Clin Ther 26: 980\u2013990.","journal-title":"Clin Ther"},{"key":"BFnpp201240_CR23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","volume":"63","author":"SL Foote","year":"1983","unstructured":"Foote SL, Bloom FE, Aston-Jones G (1983). Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63: 844\u2013914.","journal-title":"Physiol Rev"},{"key":"BFnpp201240_CR24","first-page":"266","volume":"24","author":"LS Forno","year":"1966","unstructured":"Forno LS (1966). Pathology of Parkinsonism. J Neurosurg 24: 266\u2013271.","journal-title":"J Neurosurg"},{"key":"BFnpp201240_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.neurobiolaging.2010.04.003","volume":"33","author":"BM Francis","year":"2012","unstructured":"Francis BM, Kim J, Barakat ME, Fraenkl S, Yucel YH, Peng S et al (2012). Object recognition memory and BDNF expression are reduced in young TgCRND8 mice. Neurobiol Aging 33: 555\u2013563.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Pyschiatry 66: 137\u2013147.","journal-title":"J Neurol Neurosurg Pyschiatry"},{"key":"BFnpp201240_CR27","unstructured":"Galeotti N, Ghelardini C (2011). Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signaling pathway by protein kinase C in mood modulation. Int J Neuropsychopharmacol; e-pub ahead of print 20 June 2011."},{"key":"BFnpp201240_CR28","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/ana.410320510","volume":"32","author":"DC German","year":"1992","unstructured":"German DC, Manaye KF, White III CL, Woodward DJ, McIntire DD, Smith WK et al (1992). Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32: 667\u2013676.","journal-title":"Ann Neurol"},{"key":"BFnpp201240_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0891-0618(03)00046-2","volume":"26","author":"A Gonzalo-Ruiz","year":"2003","unstructured":"Gonzalo-Ruiz A, Gonzalez I, Sanz-Anquela JM (2003). Effects of \u03b2-amyloid protein on serotonergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat. J Chem Neuroanat 26: 153\u2013169.","journal-title":"J Chem Neuroanat"},{"key":"BFnpp201240_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","volume":"28","author":"A Grudzien","year":"2007","unstructured":"Grudzien A, Shaw P, Weintraub S, Bigio E, Mash DC, Mesulam MM (2007). Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 28: 327\u2013335.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0197-0186(85)90050-6","volume":"7","author":"J Hardy","year":"1985","unstructured":"Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P et al (1985). Transmitter deficits in Alzheimer's disease. Neurochem Int 7: 545\u2013563.","journal-title":"Neurochem Int"},{"key":"BFnpp201240_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0006-8993(86)90699-2","volume":"381","author":"SI Harik","year":"1986","unstructured":"Harik SI, McCracken KA (1986). Age-related increase in presynaptic noradrenergic markers of the rat cerebral cortex. Brain Res 381: 125\u2013130.","journal-title":"Brain Res"},{"key":"BFnpp201240_CR33","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1073\/pnas.0909586107","volume":"107","author":"MT Heneka","year":"2010","unstructured":"Heneka MT, Nadrigny F, Regen T, Martinez-Hernandez A, Dumitrescu-Ozimek L, Terwel D et al (2010). Locus coeruleus controls AD pathology by modulating microglial functions through norepinephrine. PNAS 107: 6058\u20136063.","journal-title":"PNAS"},{"key":"BFnpp201240_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","volume":"26","author":"MT Heneka","year":"2006","unstructured":"Heneka MT, Ramanathan M, Jacobs AH, Dumitrescu-Ozimek L, Bilkei-Gorzo A, Debeir T (2006). Locus coeruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J Neurosci 26: 1343\u20131354.","journal-title":"J Neurosci"},{"key":"BFnpp201240_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1176\/jnp.16.3.261","volume":"16","author":"N Herrmann","year":"2004","unstructured":"Herrmann N, Lanctot KL, Khan LR (2004). The role of norepinephrine in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci 16: 261\u2013276.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"BFnpp201240_CR36","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1242\/dev.00565","volume":"130","author":"PC Holm","year":"2003","unstructured":"Holm PC, Rodriguez FJ, Kresse A, Canals JM, Silos-Santiago I, Arenas E (2003). Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons. Development 130: 3535\u20133545.","journal-title":"Development"},{"key":"BFnpp201240_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0304-3940(01)01963-2","volume":"307","author":"Y Ishida","year":"2001","unstructured":"Ishida Y, Shirokawa T, Komatsu Y, Isobe K (2001). Changes in cortical noradrenergic axon terminals of locus coeruleus neurons in aged F344 rats. Neurosci Lett 307: 197\u2013199.","journal-title":"Neurosci Lett"},{"key":"BFnpp201240_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD et al (2000). A\u03b2 peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature 408: 979\u2013982.","journal-title":"Nature"},{"key":"BFnpp201240_CR39","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","volume":"57","author":"D Jardanhazi-Kurutz","year":"2010","unstructured":"Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A et al (2010). Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits. Neurochem Int 57: 375\u2013382.","journal-title":"Neurochem Int"},{"key":"BFnpp201240_CR40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuroscience.2010.11.052","volume":"176","author":"D Jardanhazi-Kurutz","year":"2011","unstructured":"Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Thiele A, Heneka MT (2011). Distinct adrenergic system changes and neuroinflammation in response to induced locus coeruleus degeneration in APP\/PS1 transgenic mice. Neuroscience 176: 396\u2013407.","journal-title":"Neuroscience"},{"key":"BFnpp201240_CR41","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","volume":"28","author":"S Kalinin","year":"2007","unstructured":"Kalinin S, Gavrilyuk V, Polak PE, Vasser R, Zhao J, Heneka MT et al (2007). Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging 28: 1206\u20131214.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR42","unstructured":"Kalinin S, Polak PE, Lin SX, Sakharkar AJ, Pandey SC, Feistein DL (2011). The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease. Neurobiol Aging; e-pub ahead of print 24 June 2011."},{"key":"BFnpp201240_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s00406-007-0764-9","volume":"258","author":"T Leyhe","year":"2008","unstructured":"Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C (2008). Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 258: 124\u2013128.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp201240_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.neulet.2011.01.035","volume":"492","author":"K Ma","year":"2011","unstructured":"Ma K, Mount HTJ, McLaurin J (2011). Region-specific distribution of \u03b2-amyloid peptide and cytokine expression in TgCRND8 mice. Neurosci Lett 492: 5\u201310.","journal-title":"Neurosci Lett"},{"key":"BFnpp201240_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/cne.903580105","volume":"358","author":"KF Manaye","year":"1995","unstructured":"Manaye KF, McIntire DD, Mann DM, German DC (1995). Locus coeruleus cell loss in the aging human brain: a non-random process. J Comp Neurol 358: 79\u201387.","journal-title":"J Comp Neurol"},{"key":"BFnpp201240_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/jnnp.45.2.113","volume":"45","author":"DMA Mann","year":"1982","unstructured":"Mann DMA, Yates PO, Hawkes J (1982). The noradrenergic system in Alzheimer's and multi-infarct dementias. J Neurol Neurosurg Psychiatry 45: 113\u2013119.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFnpp201240_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0022-510X(86)90179-6","volume":"76","author":"B Marcyniuk","year":"1986","unstructured":"Marcyniuk B, Mann DMA, Yates PO (1986). The topography of cell loss from locus coeruleus in Alzheimer's disease. J Neurol Sci 76: 335\u2013345.","journal-title":"J Neurol Sci"},{"key":"BFnpp201240_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","volume":"45","author":"MR Marien","year":"2004","unstructured":"Marien MR, Colpaert FC, Rosenquist AC (2004). Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45: 38\u201378.","journal-title":"Brain Res Rev"},{"key":"BFnpp201240_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0197-4580(03)00093-9","volume":"25","author":"W Matsunaga","year":"2004","unstructured":"Matsunaga W, Shirokawa T, Isobe K (2004). BDNF is necessary for maintenance of noradrenergic innervations in the aged rat brain. Neurobiol Aging 25: 341\u2013348.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","volume":"51","author":"KL Matthews","year":"2002","unstructured":"Matthews KL, Chen CP, Esiri MM, Keene J, Minger SL, Francis PT (2002). Noradrenergic changes, aggressive behaviour and cognition in patients with dementia. Biol Psychiatry 51: 407\u2013416.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201240_CR51","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1523\/JNEUROSCI.4632-08.2009","volume":"29","author":"CA Mej\u00edas-Aponte","year":"2009","unstructured":"Mej\u00edas-Aponte CA, Drouin C, Aston-Jones G (2009). Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centres. Neuroscience 29: 3613\u20133626.","journal-title":"Neuroscience"},{"key":"BFnpp201240_CR52","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/mds.21010","volume":"21","author":"GE Meredith","year":"2006","unstructured":"Meredith GE, Kang UJ (2006). Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord 21: 1595\u20131606.","journal-title":"Mov Disord"},{"key":"BFnpp201240_CR53","first-page":"1303","volume":"30","author":"T Moroji","year":"1978","unstructured":"Moroji T, Takahashi K, Ikeda C (1978). Levels of biogenic amines and their metabolites in rat whole brain after rapid tissue fixation with microwave irradiation. No To Skinkei 30: 1303\u20131308.","journal-title":"No To Skinkei"},{"key":"BFnpp201240_CR54","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1046\/j.1471-4159.2003.02278.x","volume":"88","author":"HTJ Mount","year":"2004","unstructured":"Mount HTJ, Martel J-C, Fluit P, Wu Y, Gallo-Hendrikx E, Cosi C et al (2004). Progressive sensorimotor impairment is not associated with reduced dopamine and high energy phosphate donors in a model of ataxia-telangiectasia. J Neurochem 88: 1449\u20131454.","journal-title":"J Neurochem"},{"key":"BFnpp201240_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0091-3057(96)00353-X","volume":"57","author":"M Ohno","year":"1997","unstructured":"Ohno M, Yoshimatsu A, Kobayashi M, Watanabe S (1997). Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats. Pharmacol Biochem Behav 57: 257\u2013261.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201240_CR56","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0006-8993(87)90018-7","volume":"414","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Francis PT, Bowen DM, Benton JS, Neary D, Mann DM et al (1987b). Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease. Brain Res 414: 365\u2013375.","journal-title":"Brain Res"},{"key":"BFnpp201240_CR57","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0006-8993(87)91408-9","volume":"401","author":"AM Palmer","year":"1987","unstructured":"Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM (1987a). Monoaminergic innervations of the frontal and temporal lobes in Alzheimer's disease. Brain Res 401: 231\u2013238.","journal-title":"Brain Res"},{"key":"BFnpp201240_CR58","doi-asserted-by":"publisher","first-page":"9321","DOI":"10.1523\/JNEUROSCI.4736-08.2009","volume":"29","author":"S Peng","year":"2009","unstructured":"Peng S, Garzon DJ, Marchese M, Klein W, Ginsberg SD, Francis BM et al (2009). Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 29: 9321\u20139329.","journal-title":"J Neurosci"},{"key":"BFnpp201240_CR59","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/sj.npp.1300954","volume":"31","author":"P Rizk","year":"2006","unstructured":"Rizk P, Salazar J, Raisman-Vozari R, Marien M, Ruberg M, Colpaert F et al (2006). The alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells. Neuropsychopharmacology 31: 1146\u20131157.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201240_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0091-3057(82)90452-X","volume":"16","author":"T Schallert","year":"1982","unstructured":"Schallert T, Upchurch M, Lobaugh N, Farrar SB, Spirduso WW, Gilliam P et al (1982). Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol Biochem Behav 16: 455\u2013462.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp201240_CR61","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neurobiolaging.2009.04.015","volume":"32","author":"M Srivareerat","year":"2011","unstructured":"Srivareerat M, Tran TT, Salim S, Aleisa AM, Alkadhi KA (2011). Chronic nicotine restores normal A\u03b2 levels and prevents short-term memory and E-LTP impairment in A\u03b2 rat model of Alzheimer's disease. Neurobiol Aging 32: 834\u2013844.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR62","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85: 367\u2013370.","journal-title":"Psychopharmacology"},{"key":"BFnpp201240_CR63","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.neurobiolaging.2008.08.003","volume":"31","author":"TR Stoub","year":"2010","unstructured":"Stoub TR, Rogalski EJ, Leurgans S, Bennett DA, DeToledo-Morrell L (2010). Rate of entorhinal and hippocampal atrophy in incipient and mild AD: relation to memory function. Neurobiol Aging 31: 1089\u20131098.","journal-title":"Neurobiol Aging"},{"key":"BFnpp201240_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0006-8993(91)90992-5","volume":"542","author":"R Strong","year":"1991","unstructured":"Strong R, Huang JS, Huang SS, Chung HD, Hale C, Burke WJ (1991). Degeneration of the cholinergic innervation of the locus coeruleus in Alzheimer's disease. Brain Res 542: 23\u201328.","journal-title":"Brain Res"},{"key":"BFnpp201240_CR65","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1523\/JNEUROSCI.4265-05.2006","volume":"26","author":"P Szot","year":"2006","unstructured":"Szot P, White SS, Greenup JL, Leverenz JB, Peskind ER, Raskind MA (2006). Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with lewy bodies. J Neurosci 26: 467\u2013478.","journal-title":"J Neurosci"},{"key":"BFnpp201240_CR66","doi-asserted-by":"crossref","unstructured":"Tanghe A, Termont A, Merchiers P, Schilling S, Demuth H, Scrocchi L et al (2010). Pathological Hallmarks, clinical parallels, and value for drug testing in Alzheimer's disease of the APP[V717I] London transgenic mouse model. Int J Alzheimer Dis; e-pub ahead of print 2 September 2010.","DOI":"10.4061\/2010\/417314"},{"key":"BFnpp201240_CR67","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0306-4522(98)00392-3","volume":"89","author":"S Tellez","year":"1999","unstructured":"Tellez S, Colpaert F, Marien M (1999). \u03b12-Adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience 89: 1041\u20131050.","journal-title":"Neuroscience"},{"key":"BFnpp201240_CR68","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K et al (2000). Sequence of abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59: 733\u2013748.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFnpp201240_CR69","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002). Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58: 1791\u20131800.","journal-title":"Neurology"},{"key":"BFnpp201240_CR70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.106.022715","volume":"70","author":"S Traver","year":"2006","unstructured":"Traver S, Marien M, Martin E, Hirsch EC, Michel PP (2006). The phenotypic differentiation of locus coeruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway. Mol Pharmacol 70: 30\u201340.","journal-title":"Mol Pharmacol"},{"key":"BFnpp201240_CR71","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1124\/mol.104.007864","volume":"67","author":"S Traver","year":"2005","unstructured":"Traver S, Salthun-Lassalle B, Marien M, Hirsch EC, Colpaert F, Michel PP (2005). The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol 67: 1882\u20131891.","journal-title":"Mol Pharmacol"},{"key":"BFnpp201240_CR72","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-004-2132-z","volume":"180","author":"D Van Dam","year":"2005","unstructured":"Van Dam D, Abramowski D, Staufenbiel M, De Deyn PP (2005). Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model. Psychopharmacology 180: 177\u2013190.","journal-title":"Psychopharmacology"},{"key":"BFnpp201240_CR73","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.expneurol.2005.03.004","volume":"194","author":"A Veyrac","year":"2005","unstructured":"Veyrac A, Didier A, Colpaert F, Jourdan F, Marien M (2005). Activation of noradrenergic transmission by \u03b12-adrenoceptor antagonists counteract deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb. Exp Neurol 194: 444\u2013456.","journal-title":"Exp Neurol"},{"key":"BFnpp201240_CR74","first-page":"163","volume":"40","author":"PL Wood","year":"1988","unstructured":"Wood PL, Altar CA (1988). Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacol Rev 40: 163\u2013187.","journal-title":"Pharmacol Rev"},{"key":"BFnpp201240_CR75","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1471-4159.1987.tb04131.x","volume":"48","author":"PL Wood","year":"1987","unstructured":"Wood PL, Kim HS, Altar CA (1987). In Vivo assessment of dopamine and noradrenaline release in rat neocortex: gas chromatography-mass spectrometry measurement of 3-Methoxytyramine and normetanephrine. J Neurochem 48: 574\u2013579.","journal-title":"J Neurochem"},{"key":"BFnpp201240_CR76","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2003","unstructured":"Zarow C, Lyness SA, Mortimer JA, Chui HC (2003). Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurology 60: 337\u2013341.","journal-title":"Arch Neurology"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:43:51Z","timestamp":1684453431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":76,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["BFnpp201240"],"URL":"https:\/\/doi.org\/10.1038\/npp.2012.40","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]}}}